Importantly, we demonstrate that specific CYP46A1 expression in astrocytes leads to decreased mHTT aggregates in both astrocytes and neurons, improves motor function, mitigates MSN atrophy, improves MSN spine density, and activates the cholesterol pathway with increased production of cholesterol precursors. Here, CYP46A1 is linked to Atrophy.